Clinical Trials in Los Angeles

Showing 12681-12700 of 15,156 trials

Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection

NCT00059462

The purpose of this study is to evaluate the safety of the experimental drug Bay 50-4798 in HIV positive patients receiving HAART and to test the drug's effect on the CD4+ T-cell count.

HIV Infections

Bayer56 participantsStarted Dec 2002

Birmingham, Alabama, United States • Davis, California, United States • Los Angeles, California, United States +8 more locations

COMPLETEDPhase 4< 1 mile

A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency

NCT01289847

The main objective is to determine the efficacy of Gammaplex by measuring the number of serious acute bacterial infections during treatment with Gammaplex over a 12 month period. The secondary objectives are to assess the safety and tolerability of Gammaplex and to compare the data collected from adult subjects with PID from the GMX01 study

Primary Immune Deficiency DisordersCommon Variable ImmunodeficiencyX-linked Agammaglobulinemia+2 more

Bio Products Laboratory25 participantsStarted Mar 2011

Irvine, California, United States • Los Angeles, California, United States • Centennial, Colorado, United States +7 more locations

Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection

A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency

Find Trials by Condition in Los Angeles

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy

Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors

Empiric Therapy of Mucopurulent Cervicitis (MPC)

Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne

Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections

Study to Evaluate the PK, Relative Bioavailability and Safety of TG-2349 With Single Oral Dose Under Fed Condition in Healthy Volunteers

Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa

Accuracy of Dilution of EUS-FNA Pancreatic Cyst Fluid for Carcinoembryonic Antigen (CEA) Measurement

Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes

A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive Malignancies

Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma